Home › Heart Failure › NCT05056129
Sensor-controlled Digital Game for Heart Failure Self-management: A Clinical Trial
Sensor-controlled Digital Game for Heart Failure Selfmanagement Behavior Adherence: A Randomized Controlled Trial
Who can join
Ages 45 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Age 45 years or older * New York Heart Association (NYHA) heart failure classification of I to III that permits minimal physical activity without discomfort * have experienced HF hospitalization in the past 12 months * be fluent in English * Pass a mini-cognitive screen * Score of less than 2 (able to independently walk without using a cane or walker) on the Outcome and Assessment Information Set item for ambulation/locomotion Exclusion Criteria: * severe visual (e.g., legally blind) or tactile (e.g., severe arthritis) impairments that adversely prevent the use of a smartphone or sensor devices; * a history of renal failure, which adversely affects HF prognosis * a diagnosis of an end-stage or terminal illness (e.g., cancer) * undergone heart transplantation, or implantation of a durable mechanical circulatory support device (e.g., left ventricular assist device) due to unique self-management needs.
About the study
This study evaluates a sensor-controlled digital game (SCDG) to motivate self-management behaviors of weight monitoring and physical activity in adults with heart failure (HF). Half of the participants will receive the SCDG app and weight monitoring and physical activity sensors and the other half will receive only the weight monitoring and physical activity sensors.
What is being tested
- Sensor-controlled digital game (SCDG) (behavioral)
- Sensor Only (behavioral)
Sponsor: University of Texas at Austin · Participants: 200 · Started: Nov 1, 2022
Contact the study team
- Angelica Rangel, MS · Phone: 512-956-8714
Official record on ClinicalTrials.gov — NCT05056129
Locations in the U.S.
| Texas | The University of Texas Austin, Austin |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.